混合表示学习用于晚年抑郁症的认知诊断,超过5年,具有结构性MRI
Lintao Zhang1, Lihong Wang2, Minhui Yu3
1School of Information Science and Engineering, Linyi University, Linyi, Shandong 27600, China; Department of Radiology and BRIC, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
Medical image analysis
|March 10, 2024
概括
这项研究引入了一种混合表示学习框架,用于预测晚年抑郁症 (LLD) 的老年人的认知衰退. 该模型准确地识别LLD,并使用MRI扫描预测未来的认知障碍.
科学领域:
- 神经科学是一个神经科学.
- 人工智能的人工智能
- 老年学是一门学科.
背景情况:
- 晚年抑郁症 (LLD) 在老年人中很常见,经常与认知障碍 (CI) 一起发生.
- 虽然LLD可能会增加患阿尔茨海默病 (AD) 的风险,但它的异质表现表明其潜在的生物机制多样化.
- 整合神经成像和临床数据的机器学习正在推动LLD研究,但很少有研究专注于使用结构性MRI (sMRI) 预测认知结果.
研究的目的:
- 开发和验证混合表示学习 (HRL) 框架,用于在五年内预测LLD患者的认知诊断.
- 评估框架能够区分具有LLD和健康对照的认知正常个体.
- 在LLD患者中预测认知状态的进展 (CI或AD与保持认知正常).
主要方法:
- 开发一种混合表示学习 (HRL) 框架,利用T1加权的sMRI数据.
- 使用深度神经网络提取预测导向的MRI特征.
- 集成深度神经网络功能与手工制作的MRI功能通过变压器编码器用于认知诊断预测.
主要成果:
- 与经典机器学习和最先进的深度学习方法相比,HRL框架在识别LLD和预测认知诊断方面表现优异.
- 从两个协调研究中对294个主题的验证证实了该框架的有效性.
- 该模型成功地完成了两个关键任务:将LLD患者与健康对照区分开来,并预测LLD患者未来的认知能力下降.
结论:
- 拟议的HRL框架为早期识别和预测晚年抑郁症认知结果提供了一个有希望的方法.
- 这种方法利用sMRI数据的先进机器学习技术来解决LLD的异质性.
- 进一步的研究可以建立在这个框架上,以提高LLD和相关认知障碍的诊断准确性和治疗策略.
相关概念视频
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Imaging Studies for Cardiovascular System IV: CMRI
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


